PTCE Top 200 · #188

Evolocumab

Repatha

Evolocumab is the generic name for the brand-name drug Repatha. It is a pcsk9 inhibitor used to treat high cholesterol (familial). On the PTCE Top 200 drug list, Evolocumab ranks #188 and is one of the most frequently tested cardiovascular medications — commonly quizzed on its brand–generic pair, drug class, and key side effects.

Generic nameEvolocumab
Brand name(s)Repatha
Drug classPCSK9 inhibitor
Class groupCardiovascular
Common usehigh cholesterol (familial)
DEA scheduleUnscheduled
AvailabilityPrescription only (Rx)

What is Evolocumab used for?

Lowering LDL-C as an adjunct to diet (e.g., familial hypercholesterolemia, established ASCVD) and reduction of cardiovascular risk in certain patients (product-specific).

What drug class is Evolocumab?

Evolocumab is a PCSK9 inhibitor in the Cardiovascular group. Knowing the class is the fastest way to predict its uses, side effects, and the brand↔generic pairs the PTCE tests.

Common side effects of Evolocumab

Major interactions

Is Evolocumab a controlled substance?

No. Evolocumab is not a federally controlled substance (it is unscheduled by the DEA).

How to remember Evolocumab (PTCE mnemonic)

REPATHA REPaths LDL out — evolo-CUMAB blocks PCSK9 (→ more LDL receptors, lower LDL ~60%). SubQ q2wk or monthly; injection-site reactions; very expensive add-on to statin.
lightbulb
PTCE exam tip

Evolocumab is the injectable cholesterol biologic — a PCSK9 -mab given every 2–4 weeks and kept refrigerated — for patients statins alone can't get to goal.

Evolocumab FAQ

What is the brand name for Evolocumab?

The brand name for Evolocumab is Repatha.

What is Evolocumab used for?

Evolocumab is used to treat high cholesterol (familial). Lowering LDL-C as an adjunct to diet (e.g., familial hypercholesterolemia, established ASCVD) and reduction of cardiovascular risk in certain patients (product-specific).

What drug class is Evolocumab?

Evolocumab is a PCSK9 inhibitor (Cardiovascular group).

Is Evolocumab a controlled substance?

No. Evolocumab is not a federally controlled substance (it is unscheduled by the DEA).

Related drugs in the Cardiovascular group

Drill Evolocumab the way the PTCE asks it

RxReflex turns the Top 200 drugs into fast flashcard rounds, a guided Learn path, pharmacy math, and 40+ cheat sheets. Free to start.

Last reviewed June 25, 2026. Educational use only — not medical advice. Verify clinical specifics with your pharmacist or a current label source such as DailyMed. RxReflex is not affiliated with or endorsed by the Pharmacy Technician Certification Board (PTCB).